Kostas Kostarelos

Kostas Kostarelos

Nanomedicine Lab, University of Manchester

Affiliated withUniversity of Manchester

Research Area

Biography

Kostas Kostarelos has not added Biography.
If you are Kostas Kostarelos and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
<em>In vivo</em> Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors
Publication title

Cited by 19

2013

Other Publications

Article
Year
Rational design and engineering of delivery systems for therapeutics: biomedical exercises in colloid and surface science.

Advances in colloid and interface science| PubMed ID: 14672846

2003
Binding and interstitial penetration of liposomes within avascular tumor spheroids.

International journal of cancer. Journal international du cancer| PubMed ID: 15382056

2004
Functionalized carbon nanotubes for plasmid DNA gene delivery.

Angewandte Chemie (International ed. in English)| PubMed ID: 15455428

2004
2005
2005
Biomedical applications of functionalised carbon nanotubes.

Chemical communications (Cambridge, England)| PubMed ID: 15672140

2005
2005
Internal microdosimetry for single cells in radioimmunotherapy of B-cell lymphoma.

Cancer biotherapy & radiopharmaceuticals| PubMed ID: 15869460

2005
Synthesis and application of integrin targeting lipopeptides in targeted gene delivery.

Chembiochem : a European journal of chemical biology| PubMed ID: 15937988

2005
2005
Applications of carbon nanotubes in drug delivery.

Current opinion in chemical biology| PubMed ID: 16233988

2005
2005
2005
2005
Carbon nanotubes: on the road to deliver.

Current drug delivery| PubMed ID: 16305427

2005
2006
Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 16492781

2006
Double functionalization of carbon nanotubes for multimodal drug delivery.

Chemical communications (Cambridge, England)| PubMed ID: 16518484

2006
Carbon nanotubes as nanomedicines: from toxicology to pharmacology.

Advanced drug delivery reviews| PubMed ID: 17113677

2006
Construction of nanoscale multicompartment liposomes for combinatory drug delivery.

International journal of pharmaceutics| PubMed ID: 17223294

2007
2007
Establishing nanomedicine.

Nanomedicine (London, England)| PubMed ID: 17716156

2006
2007
The emergence of nanomedicine: a field in the making.

Nanomedicine (London, England)| PubMed ID: 17716200

2006
2007
Functionalized carbon nanotubes in drug design and discovery.

Accounts of chemical research| PubMed ID: 17867649

2008
Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics.

Chemical communications (Cambridge, England)| PubMed ID: 18188467

2008
Opportunities and challenges of carbon-based nanomaterials for cancer therapy.

Expert opinion on drug delivery| PubMed ID: 18318654

2008
2008
2008
Artificial envelopment of nonenveloped viruses: enhancing adenovirus tumor targeting in vivo.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 18556649

2008
The long and short of carbon nanotube toxicity.

Nature biotechnology| PubMed ID: 18612299

2008
2007
Carbon-nanotube shape and individualization critical for renal excretion.

Small (Weinheim an der Bergstrasse, Germany)| PubMed ID: 18666166

2008
Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer.

Small (Weinheim an der Bergstrasse, Germany)| PubMed ID: 18711753

2008
2009
2008
2008
Designer adenoviruses for nanomedicine and nanodiagnostics.

Trends in biotechnology| PubMed ID: 19251331

2009
2009
2009
2009
2009
2010
2009
Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 20150514

2010
2010
2010
Nanorobots for medicine: how close are we?

Nanomedicine (London, England)| PubMed ID: 20394527

2010
Assessment of cellular uptake and cytotoxicity of carbon nanotubes using flow cytometry.

Methods in molecular biology (Clifton, N.J.)| PubMed ID: 20422386

2010
2010
2010
Carbon nanotubes: Fibrillar pharmacology.

Nature materials| PubMed ID: 20864939

2010
Hybrid polymer-grafted multiwalled carbon nanotubes for in vitro gene delivery.

Small (Weinheim an der Bergstrasse, Germany)| PubMed ID: 20878655

2010
2010
2011
Doxorubicin-loaded lipid-quantum dot hybrids: surface topography and release properties.

International journal of pharmaceutics| PubMed ID: 21315141

2011
Cytotoxic assessment of carbon nanotube interaction with cell cultures.

Methods in molecular biology (Clifton, N.J.)| PubMed ID: 21424457

2011
2011
Antibody covalent immobilization on carbon nanotubes and assessment of antigen binding.

Small (Weinheim an der Bergstrasse, Germany)| PubMed ID: 21608125

2011
2011
Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 21690348

2011
Making carbon nanotubes biocompatible and biodegradable.

Chemical communications (Cambridge, England)| PubMed ID: 21776531

2011
2011
2011
Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 22084097

2011
2011
2012
Targeting carbon nanotubes against cancer.

Chemical communications (Cambridge, England)| PubMed ID: 22428156

2012
2012
Therapeutics, imaging and toxicity of nanomaterials in the central nervous system.

Journal of controlled release : official journal of the Controlled Release Society| PubMed ID: 22512901

2012
2012
2012
2012
The alluring potential of functionalized carbon nanotubes in drug discovery.

Expert opinion on drug discovery| PubMed ID: 22823208

2010
Liposome-gold nanorod hybrids for high-resolution visualization deep in tissues.

Journal of the American Chemical Society| PubMed ID: 22852749

2012
2012
2013
2013
Safety considerations for graphene: lessons learnt from carbon nanotubes.

Accounts of chemical research| PubMed ID: 23163827

2013
2013
2013
Asbestos-like pathogenicity of long carbon nanotubes alleviated by chemical functionalization.

Angewandte Chemie (International ed. in English)| PubMed ID: 23319294

2013
2013
2013
2013
Prospects and challenges of graphene in biomedical applications.

Advanced materials (Deerfield Beach, Fla.)| PubMed ID: 23494834

2013
2013
Pulmonary DWCNT exposure causes sustained local and low-level systemic inflammatory changes in mice.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V| PubMed ID: 23542608

2013
2013
2013
2013
2013
Carbon nanotubes in medicine and biology - Safety and toxicology.

Advanced drug delivery reviews| PubMed ID: 24211669

2013
Hemotoxicity of carbon nanotubes.

Advanced drug delivery reviews| PubMed ID: 24211768

2013
Carbon nanotubes in medicine & biology - Therapy and diagnostics.

Advanced drug delivery reviews| PubMed ID: 24220279

2013
2013